EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?

Ilhami Yuksel, Yavuz Cagir, Ali Atay

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2023.11.039 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Ilhami Yuksel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkey; Department of Gastroenterology, Ankara Yildirim Beyazit University Scho…. Hauptthemen laut MEDLINE: Immunologic Factors, Antibodies, Monoclonal. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunologic FactorsAntibodies, MonoclonalHumansInfliximabCombined Modality TherapyDrug Therapy, CombinationTreatment OutcomeGastrointestinal Agents

Substanzen

InfliximabImmunologic FactorsAntibodies, MonoclonalGastrointestinal Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkey; Department of Gastroenterology, Ankara Yildirim Beyazit University School of Medicine, Ankara, Turkey. Electronic address: yukselilhami@hotma…
  • Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkey.

Zitieren

APA

Yuksel, I., Cagir, Y., & Atay, A. (2024). Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.11.039

Vancouver

Yuksel I, Cagir Y, Atay A. Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.11.039

BibTeX
@article{Yuksel2024,
  author = {Yuksel, Ilhami and Cagir, Yavuz and Atay, Ali},
  title = {Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2023.11.039}
}
Kostenlos starten →